Elizabeth Raetz

Elizabeth Raetz

UNVERIFIED PROFILE

Are you Elizabeth Raetz?   Register this Author

Register author
Elizabeth Raetz

Elizabeth Raetz

Publications by authors named "Elizabeth Raetz"

Are you Elizabeth Raetz?   Register this Author

100Publications

3796Reads

14Profile Views

Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology Group.

Br J Haematol 2019 Jul 7;186(2):274-285. Epub 2019 Apr 7.

Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15919DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606340PMC
July 2019

Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization.

J Clin Oncol 2018 10 23;36(29):2926-2934. Epub 2018 Aug 23.

Stuart S. Winter, Children's Minnesota Cancer and Blood Disorders Program, Minneapolis, MN; Kimberly P. Dunsmore, Carilion Clinic, Roanoke, VA; Meenakshi Devidas and Zhiguo Chen, University of Florida, Gainesville, FL; Brent L. Wood, Seattle Children's Hospital, Seattle, WA; Natia Esiashvili, Emory University, Atlanta, GA; Nancy Eisenberg, University of New Mexico Health Sciences Center, Albuquerque, NM; Nikki Briegel, Princess Margaret Hospital for Children, Perth, Western Australia, Australia; Robert J. Hayashi, St Louis Children's Hospital, St Louis, MO; Julie M. Gastier-Foster, Nationwide Children's Hospital; Julie M. Gastier-Foster and Nyla A. Heerema, Ohio State University, Columbus, OH; Andrew J. Carroll, University of Alabama at Birmingham, Birmingham, AL; Barbara L. Asselin, University of Rochester Medical Center and Wilmot Cancer Institute, Rochester; Elizabeth A. Raetz and William L. Carroll, Perlmutter Cancer Center at NYU Langone Health, New York, NY; Paul S. Gaynon, Children's Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California, San Francisco, San Francisco, CA; Michael J. Borowitz, Johns Hopkins University, Baltimore, MD; Karen R. Rabin, Baylor College of Medicine, Houston; Naomi J. Winick, University of Texas Southwestern, Dallas, TX; Patrick A. Zweidler-Mckay, ImmunoGen, Waltham, MA; and Stephen P. Hunger, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.77.7250DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366301PMC
October 2018

Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622.

J Clin Oncol 2018 08 29;36(22):2306-2314. Epub 2018 May 29.

William B. Slayton, John A. Kairalla, Meenakshi Devidas, Xinlei Mi, and Sherri L. Mizrahy, University of Florida, Gainesville, FL; Kirk R. Schultz, BC Children's Research Institute, University of British Columbia, Vancouver, British Columbia, Canada; Michael A. Pulsipher, Children's Hospital of Los Angeles, Los Angeles; Lance Sieger, University of California Los Angles-Harbor, Torrance; Mignon L. Loh, University of California San Francisco, San Francisco, CA; Bill H. Chang, Oregon Health and Science University, Portland, OR; Charles Mullighan, Ilaria Iacobucci, and Thomas Merchant, St Jude's Research Hospital, Memphis, TN; Lewis B. Silverman, Dana-Farber Cancer Institute, Boston, MA; Michael J. Borowitz, Johns Hopkins University, Baltimore, MD; Andrew J. Carroll, University of Alabama at Birmingham, Birmingham, AL; Nyla A. Heerema, Ohio State University; Julie M. Gastier-Foster, Nationwide Children's Hospital, Columbus, OH; Brent L. Wood, University of Washington Seattle, Seattle, WA; Valerie I. Brown, Penn State Health Children's Hospital, Hershey; Stephen P. Hunger, Children's Hospital of Philadelphia, Philadelphia, PA; Marilyn J. Siegel, Washington University School of Medicine, St Louis, MO; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; and William L. Carroll, New York University Langone Health Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.7228DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067800PMC
August 2018

Identifying patient- and family-centered outcomes relevant to inpatient versus at-home management of neutropenia in children with acute myeloid leukemia.

Pediatr Blood Cancer 2018 04 29;65(4). Epub 2017 Dec 29.

Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26927DOI Listing
April 2018

Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group.

Pediatr Blood Cancer 2018 03 1;65(3). Epub 2017 Nov 1.

Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26873DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839116PMC
March 2018

TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children.

J Clin Oncol 2018 02 4;36(6):591-599. Epub 2018 Jan 4.

Maoxiang Qian, Xueyuan Cao, Wenjian Yang, Cheng Cheng, Hui Zhang, Takaya Moriyama, Gerard Zambetti, Kim E. Nichols, Ching-Hon Pui, Charles G. Mullighan, William E. Evans, Mary V. Relling, and Jun J. Yang, St Jude Children's Research Hospital, Memphis, TN; Meenakshi Devidas and Yunfeng Dai, University of Florida, Gainesville, FL; Andrew Carroll, University of Alabama at Birmingham, Birmingham, AL; Nyla A. Heerema and Julie M. Gastier-Foster, The Ohio State University and Wexner Medical Center; Julie M. Gastier-Foster and Elaine R. Mardis, Nationwide Children's Hospital, Columbus, OH; Hui Zhang, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong; Heng Xu, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China; Elizabeth Raetz, University of Utah, Salt Lake City, UT; Eric Larsen, Maine Children's Cancer Program, Scarborough, ME; Naomi Winick, University of Texas Southwestern Medical Center, Dallas; W. Paul Bowman, Cook Children's Medical Center, Fort Worth, TX; Paul L. Martin, Duke University, Durham, NC; Robert Fulton, Washington University School of Medicine, St Louis, MO; Michael Borowitz, Johns Hopkins Medical Institute, Baltimore, MD; Brent Wood, University of Washington, Seattle, WA; William L. Carroll, New York University, New York, NY; Stephen P. Hunger, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA; and Mignon L. Loh, Benioff Children's Hospital and University of California, San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.5215DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815403PMC
February 2018

Klinefelter syndrome and 47,XYY syndrome in children with B cell acute lymphoblastic leukaemia.

Br J Haematol 2017 12 19;179(5):843-846. Epub 2016 Jul 19.

Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14258DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5247399PMC
December 2017

Reply to I.J. Cohen.

J Clin Oncol 2017 12 18;35(35):3989-3991. Epub 2017 Oct 18.

Kristina K. Hardy, Children's National Medical Center, Washington, DC; Leanne M. Embry, University of Texas at San Antonio, San Antonio, TX; John A. Kairalla, University of Florida, Gainesville, FL; Shanjun Helian, Merck, Upper Gwynedd, PA; Meenakshi Devidas, University of Florida, Gainesville, FL; F. Daniel Armstrong, University of Miami, Miami, FL; Stephen Hunger, Children's Hospital of Philadelphia, Philadelphia, PA; William L. Carroll, New York University, New York, NY; Eric Larsen, Maine Children's Cancer Program, Scarborough, ME; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; Mignon L. Loh, University of California at San Francisco, San Francisco, CA; Wenjian Yang and Mary V. Relling, St Jude Children's Research Hospital and University of Tennessee, Memphis, TN; Robert B. Noll, University of Pittsburgh, Pittsburgh, PA; and Naomi Winick, University of Texas Southwestern, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.7252DOI Listing
December 2017

How is the Ph-like signature being incorporated into ALL therapy?

Best Pract Res Clin Haematol 2017 09 15;30(3):222-228. Epub 2017 Jun 15.

Department of Pediatrics and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15216926173001
Publisher Site
http://dx.doi.org/10.1016/j.beha.2017.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053910PMC
September 2017

Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.

J Clin Oncol 2017 Aug 23;35(22):2527-2534. Epub 2017 May 23.

Naomi Winick, University of Texas Southwestern Medical Center, Dallas, TX; Meenakshi Devidas and Si Chen, University of Florida, Gainesville, FL; Kelly Maloney, Children's Hospital Colorado, Aurora, CO; Eric Larsen, Maine Children's Cancer Program, Scarborough, ME; Leonard Mattano, HARP Pharma Consulting, Mystic, CT; Michael J. Borowitz, Johns Hopkins Medical Institutions, Baltimore, MD; Andrew Carroll, University of Alabama at Birmingham, AL; Julie M. Gastier-Foster, Institute for Genomic Medicine, Nationwide Children's Hospital; Julie M. Gastier-Foster and Nyla A. Heerema, The Ohio State University School of Medicine, Columbus, OH; Cheryl Willman, University of New Mexico, Albuquerque, NM; Brent Wood, University of Washington, Seattle, WA; Mignon L. Loh, University of California, San Francisco, San Francisco, CA; Elizabeth Raetz, University of Utah, Salt Lake City, UT; Stephen P. Hunger, Children's Hospital of Philadelphia, Philadelphia, PA; and William L. Carroll, New York University Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.4774DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536164PMC
August 2017

Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology Group.

J Clin Oncol 2017 Aug 3;35(23):2700-2707. Epub 2017 Jul 3.

Kristina K. Hardy, Children's National Medical Center, Washington, DC; Leanne Embry, The University of Texas Health Science Center at San Antonio, San Antonio; Naomi Winick, University of Texas Southwestern Medical Center, Dallas, TX; John A. Kairalla and Meenakshi Devidas, Colleges of Medicine, Public Health and Health Professions, University of Florida, Gainesville; Daniel Armstrong, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL; Shanjun Helian, Merck, Upper Gwynedd; Stephen Hunger, Children's Hospital of Philadelphia, Philadelphia; Robert B. Noll, University of Pittsburgh School of Medicine, Pittsburgh, PA; William L. Carroll, New York University Medical Center, New York, NY; Eric Larsen, Maine Children's Cancer Program, Scarborough, ME; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; Mignon L. Loh, University of California, San Francisco, San Francisco, CA; and Wenjian Yang and Mary V. Relling, St Jude Children's Research Hospital; University of Tennessee Health Science Center, Memphis, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.7587DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549456PMC
August 2017

Advances in pediatric hematology/oncology.

Authors:
Elizabeth Raetz

Curr Opin Pediatr 2017 02;29(1):1-2

Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Utah, Salt Lake City, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOP.0000000000000448DOI Listing
February 2017

Beating the Clock in T-cell Acute Lymphoblastic Leukemia.

Clin Cancer Res 2017 Feb 22;23(4):873-875. Epub 2016 Dec 22.

Department of Pediatrics, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-2825DOI Listing
February 2017

T-cell acute lymphoblastic leukemia.

Hematology Am Soc Hematol Educ Program 2016 Dec;2016(1):580-588

Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2016.1.580DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142501PMC
December 2016

Seven great achievements in pediatric research in the past 40 y.

Pediatr Res 2016 09;80(3):330-7

Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/pr.2016.95DOI Listing
September 2016

A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL08P1.

J Pediatr Hematol Oncol 2016 08;38(6):409-17

*Mayo Clinic Children's Center, Division of Pediatric Hematology Oncology, Rochester, MN †Children's Oncology Group Data Center Biostatistics, University of Florida, Gainesville, FL ‡Walter Reed National Military Medical Center, Congressionally Directed Medical Research Program, US Army Medical Research and Materiel Command, Fort Detrick, MD ††Department of Pathology, Johns Hopkins University Sidney Kimmel Cancer Center, John Hopkins University, Baltimore, MD §Division Pediatric Hematology-Oncology, Primary Children's Hospital, University of Utah, Salt Lake City, UT ∥Division of Pediatric Hematology Oncology, UCSF Medical Center-Mssion Bay, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA ¶Department of Genetics, Children's Hospital of Alabama, University of Alabama at Birmingham, Birmingham, AL #Nationwide Children's Hospital, Cytogenetics, The Ohio State University, Columbus, OH **Seattle Children's Hospital, Laboratory Medicine, Seattle, WA ‡‡Midwest Children's Cancer Center, MACC Fund Research Center, Milwaukee, WI §§Division of Pediatric Hematology Oncology, University of Rochester Medical Center, Rochester ¶¶Laura and Isaac Perlmutter Cancer Center at NYU Langone, Hassendfeld Children's Center, New York, NY ∥∥Division Pediatric Hematology-Oncology, UT Southwestern/Simmons Cancer Center, Dallas, TX †††Baylor College of Medicine, Comprehensive Cancer Center, Pediatric Oncology, Houston, TX ##Division of Oncology, Children's Hospital of Philadelphia ***Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0000000000000589DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955695PMC
August 2016

Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232.

J Clin Oncol 2016 07 25;34(20):2380-8. Epub 2016 Apr 25.

Eric C. Larsen, Maine Children's Cancer Program, Scarborough, ME; Meenakshi Devidas and Si Chen, University of Florida, Gainesville, FL; Wanda L. Salzer, US Army Medical Research and Materiel Command, Frederick; Michael J. Borowitz, Johns Hopkins Medical Institutions, Baltimore, MD; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT, Mignon L. Loh, University of California, San Francisco, San Francisco, CA; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Catherine Cole, Princess Margaret Hospital for Children; University of Western Australia, Perth, Western Australia, Australia; Alisa Eicher, Doernbecher Children's Hospital, Portland, OR; Maureen Haugan, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL; Mark Sorenson, University of Iowa Hospitals and Clinics, Iowa City, IA; Nyla A. Heerema and Julie M. Gastier-Foster, The Ohio State University School of Medicine, Columbus, OH; Andrew A. Carroll, University of Alabama at Birmingham, Birmingham, AL; Brent L. Wood, University of Washington, Seattle, WA; Cheryl L. Willman, University of New Mexico, Albuquerque, NM; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Stephen P. Hunger, Children's Hospital of Philadelphia; University of Pennsylvania, Philadelphia, PA; and William L. Carroll, New York University Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.4544DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981974PMC
July 2016

Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.

J Clin Oncol 2016 06 25;34(18):2133-40. Epub 2016 Apr 25.

Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children's Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children's Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children's Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children's Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children's Hospital of Philadelphia, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.5812DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962704PMC
June 2016

State of the art discovery with tumor profiling in pediatric oncology.

Am Soc Clin Oncol Educ Book 2015 :e601-7

From the Division of Pediatric Hematology/Oncology, Department of Pediatrics, NYU Langone Medical Center, New York, NY; Perlmutter Cancer Center, NYU Langone Medical Center, New York, NY; Department of Pediatrics, University of Utah, Salt Lake City, UT; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2015.35.e601DOI Listing
February 2016

New advances and future directions in pediatric hematology/oncology.

Authors:
Elizabeth Raetz

Curr Opin Pediatr 2016 Feb;28(1):1-2

Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Utah, Salt Lake City, Utah, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOP.0000000000000310DOI Listing
February 2016

Primary T cell central nervous system lymphoblastic lymphoma in a child: case report and literature review.

Childs Nerv Syst 2015 Jun 15;31(6):977-84. Epub 2015 Feb 15.

Division of Pediatric Neurosurgery, Department of Neurosurgery, Primary Children's Hospital, University of Utah, 100 North Mario Capecchi Drive, Suite 1475, Salt Lake City, UT, 84113-1100, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00381-015-2633-6DOI Listing
June 2015

Cryptococcal osteomyelitis in an adolescent survivor of T-cell acute lymphoblastic leukemia.

Pediatr Infect Dis J 2015 Jun;34(6):662-6

From the *Saul Krugman Division of Pediatric Infectious Diseases, Department of Pediatrics, New York University Medical School, New York, NY; †Division of Infectious Diseases, Boston Children's Hospital, Harvard Medical School, Boston, MA; ‡Division of Pediatric Hematology and Oncology, Department of Pediatrics, New York University Medical School, New York, NY; §Department of Molecular Genetics and Microbiology (MGM), ¶Department of Pharmacology and Cancer Biology, and ‖Department of Medicine, Duke University Medical Center, Durham, NC; **Department of Pathology, New York University Medical School, New York, NY; and ††Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/INF.0000000000000687DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431918PMC
June 2015

Spontaneous Regression of Thoracic and Extraperitoneal Glial Implants in Child With Gliomatosis Peritonei After Resection of Ovarian Teratoma.

J Pediatr Hematol Oncol 2015 Apr;37(3):230-1

Departments of *General Surgery, Division of Pediatric Surgery †Pediatrics, Division of Hematology/Oncology ‡Radiology, Division of Pediatric Radiology, New York University Langone Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0000000000000230DOI Listing
April 2015

Introduction and overview to issue on new developments in pediatric hematology/oncology.

Authors:
Elizabeth Raetz

Curr Opin Pediatr 2015 Feb;27(1):1-2

Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Utah, Salt Lake City, Utah, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOP.0000000000000178DOI Listing
February 2015

Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4.

J Clin Oncol 2014 Dec 27;32(34):3874-82. Epub 2014 Oct 27.

Anne L. Angiolillo, Reuven J. Schore, Ashley R. Lane, and Gregory H. Reaman, Children's National Medical Center, Washington, DC; Meenakshi Devidas, Colleges of Medicine, Public Health and Health Professions, University of Florida; Charlotte Wood and Hao W. Zheng, Children's Oncology Group, Gainesville, FL; Michael J. Borowitz, Johns Hopkins Medical Institutions, Baltimore; Taha Keilani, Sigma-Tau Pharmaceuticals, Gaithersburg, MD; Andrew J. Carroll, University of Alabama at Birmingham, Birmingham, AL; Julie M. Gastier-Foster and Nyla A. Heerema, Ohio State University Wexner Medical Center; Julie M. Gastier-Foster, Ohio State University College of Medicine and Nationwide Children's Hospital, Columbus, OH; Mignon L. Loh, University of California at San Francisco, San Francisco, CA; Peter C. Adamson, Children's Hospital of Philadelphia, Philadelphia, PA; Brent Wood, University of Washington, Seattle, WA; Elizabeth A. Raetz and William L. Carroll, New York University Cancer Institute, New York University Langone Medical Center, New York, NY; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; and Stephen P. Hunger, Children's Hospital Colorado and University of Colorado School of Medicine, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.5763DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239306PMC
December 2014

Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance.

Pediatr Blood Cancer 2014 Oct 29;61(10):1779-85. Epub 2014 Jun 29.

Department of Pediatric Hematology/Oncology, Laura and Isaac Perlmutter Cancer Center at New York University Langone Medical Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25119DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217284PMC
October 2014

Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.

N Engl J Med 2014 Sep;371(11):1005-15

From the Departments of Pathology (K.G.R., D.P.-T., Y.-L.Y., K. McCastlain, G.S., J.M., S.-C.C., J.C., N.S.-M., I.I., J.W., J.R.D., C.G.M.), Computational Biology and Bioinformatics (Y.L., J.B., M.R., E.H., P.G., P.N., G.W., X.C., J.Z.), Biostatistics (D.P., C.C.), Pharmaceutical Sciences (S.W.P., M.V.R., W.E.E.), and Oncology (C.-H.P., S.J.), the Pediatric Cancer Genome Project (Y.L., L.D., C.L., M.R., J.E., J.C., K.B., R.S.F., E.H., P.G., P.N., G.W., X.C., D.Y., B.V., H.M., M.V.R., W.E.E., E.M., R.K.W., J.R.D., J.Z., C.G.M.), and Cytogenetics Shared Resource (M.V.), St. Jude Children's Research Hospital, Memphis, TN; the University of New Mexico Cancer Center and School of Medicine, Albuquerque (R.C.H., I-M.C., C.L.W.); the Genome Institute at Washington University (L.D., C.L., R.S.F., E.M., R.K.W.), the Department of Genetics, Washington University School of Medicine (L.D., C.L., R.S.F., E.M., R.K.W.), and Siteman Cancer Center, Washington University (E.M., R.K.W.) - all in St. Louis; Epidemiology and Health Policy Research, College of Medicine, University of Florida, Gainesville (M.D.); the Research Institute at Nationwide Children's Hospital (S.R., A.S., J.M.G.-F.), the Department of Pathology, College of Medicine, Ohio State University (N.A.H.), and Ohio State University Comprehensive Cancer Center (G.M., C.D.B., K. Mrózek, J.K.) - all in Columbus, OH; the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (N.J.W.), Scott and White Hospitals and Clinics and Texas A&M Health Science Center, Temple (G.G.), the University of Texas Health Science Center San Antonio, San Antonio (M.F.-J.), and the Departments of Leukemia and Stem Cell Transplantation, Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston (S.M.K., M.K.) - all in Texas; Maine Children's Cancer Program, Scarborough (E.C.L.); New York University Cancer Institute, New York (W.L.C.), and the Department of Medicine (Oncology), Albert Einstein

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1403088DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191900PMC
September 2014

A phase I study of EZN-3042, a novel survivin messenger ribonucleic acid (mRNA) antagonist, administered in combination with chemotherapy in children with relapsed acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.

J Pediatr Hematol Oncol 2014 Aug;36(6):458-63

*NYU Cancer Institute and Department of Pediatrics, NYU Langone Medical Center, New York †Staten Island University Hospital, Staten Island, NY ‡Division of Hematology/Oncology §Department of Preventive Medicine, Keck School of Medicine, University of Southern California ∥Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, CA ¶St. Jude Children's Research Hospital, Memphis, TN #Pediatric Hematology and Oncology, Children's Hospitals and Clinics of Minnesota, Minneapolis, MN **Johns Hopkins University, Baltimore, MD ††Enzon Pharmaceuticals Inc., Piscataway, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0b013e3182a8f58fDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238428PMC
August 2014

The biology of relapsed acute lymphoblastic leukemia: opportunities for therapeutic interventions.

J Pediatr Hematol Oncol 2014 Aug;36(6):413-8

Division of Pediatric Hematology-Oncology, New York University Cancer Institute, New York University Langone Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0000000000000179DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264573PMC
August 2014

Refining prognosis in BCR-ABL1-positive ALL.

Blood 2014 Mar;123(11):1626-7

HUNTSMAN CANCER INSTITUTE;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-01-547570DOI Listing
March 2014

Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group.

J Clin Oncol 2013 Sep 12;31(27):3397-402. Epub 2013 Aug 12.

Nyla A. Heerema and Julie M. Gastier-Foster, The Ohio State University Wexner Medical Center; Julie M. Gastier-Foster, The Ohio State University College of Medicine and Nationwide Children's Hospital, Columbus, OH; Andrew J. Carroll, University of Alabama at Birmingham, Birmingham, AL; Meenakshi Devidas, University of Florida, Gainesville, FL; Mignon L. Loh, University of California at San Francisco, San Francisco, CA; Michael J. Borowitz, Johns Hopkins Medical Institutions, Baltimore, MD; Eric C. Larsen, Maine Children's Cancer Program, Scarborough, ME; Leonard A. Mattano Jr, Michigan State University College of Human Medicine, Kalamazoo, MI; Kelly W. Maloney and Stephen P. Hunger, Children's Hospital Colorado and University of Colorado School of Medicine, Aurora, CO; Cheryl L. Willman, University of New Mexico, Albuquerque, NM; Brent L. Wood, University of Washington, Seattle, WA; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; and William L. Carroll and Elizabeth A. Raetz, The New York University Cancer Institute, New York University Langone Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.1308DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770866PMC
September 2013

Where do we stand in the treatment of relapsed acute lymphoblastic leukemia?

Hematology Am Soc Hematol Educ Program 2012 ;2012:129-36

Division of Pediatric Hematology/Oncology, New York University Langone Medical Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2012.1.129DOI Listing
June 2013

Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia.

Pediatr Blood Cancer 2013 Jun 19;60(6):957-63. Epub 2012 Dec 19.

University of Colorado School of Medicine, The University of Colorado Cancer Center and Children's Hospital Colorado, Aurora, Colorado, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24420DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045498PMC
June 2013

Lymphoproliferative disorder that resembles heptosplenic lymphoma during maintenance treatment for T-cell acute lymphoblastic leukemia.

Pediatr Blood Cancer 2013 Jun 9;60(6):E10-2. Epub 2013 Jan 9.

Division of Pathology and Laboratory Medicine, Stony Brook University Medical Center, Stony Brook, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24442DOI Listing
June 2013

BUBR1 recruits PP2A via the B56 family of targeting subunits to promote chromosome congression.

Biol Open 2013 May 25;2(5):479-86. Epub 2013 Mar 25.

Program in Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, 8 College Road , Singapore 169857 , Singapore ; NUS Graduate School for Integrative Sciences and Engineering , 28 Medical Drive Singapore 117456 , Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1242/bio.20134051DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654266PMC
May 2013

The future role of monoclonal antibody therapy in childhood acute leukaemias.

Br J Haematol 2012 Oct 13;159(1):3-17. Epub 2012 Aug 13.

Department of Pediatrics, State University of New York at Buffalo, Buffalo, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12002DOI Listing
October 2012

Acute lymphoblastic leukemia in young adults: which treatment?

Curr Opin Oncol 2012 Sep;24(5):487-94

Section of Pediatric Hematology/Oncology, University of Chicago Comer Children's Hospital, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e32835538f8DOI Listing
September 2012

Clinical and laboratory biology of childhood acute lymphoblastic leukemia.

J Pediatr 2012 Jan 13;160(1):10-8. Epub 2011 Sep 13.

Department of Pediatrics, NYU Langone Medical Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpeds.2011.08.006DOI Listing
January 2012

Well-differentiated pancreatic neuroendocrine carcinoma in tuberous sclerosis--case report and review of the literature.

Am J Surg Pathol 2012 Jan;36(1):149-53

Department of Pathology, New York University Langone Medical Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e31823d0560DOI Listing
January 2012

Improving outcomes for high-risk ALL: translating new discoveries into clinical care.

Pediatr Blood Cancer 2011 Jun 15;56(6):984-93. Epub 2011 Feb 15.

Center for Cancer and Blood Disorders, The Children's Hospital and Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pbc.22996
Publisher Site
http://dx.doi.org/10.1002/pbc.22996DOI Listing
June 2011

Tolerability and efficacy of L-asparaginase therapy in pediatric patients with acute lymphoblastic leukemia.

J Pediatr Hematol Oncol 2010 Oct;32(7):554-63

Division of Pediatric Hematology/Oncology, Department of Pediatrics, New York University School of Medicine, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0b013e3181e6f003DOI Listing
October 2010

Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study.

Pediatr Blood Cancer 2010 Sep;55(3):421-9

Therapeutic Advances in Childhood Leukemia Consortium, USC-CHLA Institute for Pediatric Clinical Research, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.22612DOI Listing
September 2010

Dying to predict outcome.

Pediatr Blood Cancer 2010 Jul;55(1):5-6

Division of Pediatric Hematology/Oncology, Department of Pediatrics, New York University Cancer Institute, New York University School of Medicine, New York, New York 10016, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pbc.22563
Publisher Site
http://dx.doi.org/10.1002/pbc.22563DOI Listing
July 2010

Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study.

J Clin Oncol 2010 Feb 19;28(4):648-54. Epub 2009 Oct 19.

Therapeutic Advances in Childhood Leukemia Consortium, Institute for Pediatric Clinical Research and Childrens Center for Cancer and Blood Diseases, University of Southern California-Childrens Hospital Los Angeles, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.22.2950DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815999PMC
February 2010

"When can I go home?"-seeking ways to lower the burden on patients and families.

Pediatr Blood Cancer 2008 Sep;51(3):318-9

Division of Pediatric Hematology/Oncology, Department of Pediatrics, NYU Cancer Institute, NYU School of Medicine, New York 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.21625DOI Listing
September 2008